Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Bear Biotech catalogue
VIP / Vasoactive Intestinal Peptide
Neuropeptide and GPCR signalling research material
- VPAC signalling
- Smooth-muscle physiology
- Immune signalling
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is VIP / Vasoactive Intestinal Peptide?
Vasoactive intestinal peptide (VIP) is an endogenous neuropeptide with extensive physiological research across VPAC receptors, vascular tone, smooth muscle, neuroimmune signalling and gastrointestinal biology. The underlying physiology is well established, while intervention studies are smaller and context-specific.
Extensive physiology; limited small human intervention studies
Research focus
Key research areas
VIP research: a major neuroimmune and GPCR signalling peptide
Vasoactive intestinal peptide is an endogenous 28-amino-acid neuropeptide examined across receptor, secretion, smooth-muscle and circadian experiments. Intervention evidence remains limited. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- VPAC signalling
- Smooth-muscle physiology
- Immune signalling
Representative primary research
Representative research
Foundational isolation work described a vasoactive peptide extracted from small intestine in experimental preparations.
- Potent Peripheral and Splanchnic Vasodilator Peptide from Normal Gut ↗ Original discovery research for the peptide later named VIP.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- VIP / Vasoactive Intestinal Peptide
- Research category
- Neuropeptide and GPCR signalling research material
- Evidence position
- Extensive physiology; limited small human intervention studies
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
Which VPAC-receptor pathways define VIP research?
VIP / Vasoactive Intestinal Peptide is studied through VPAC-receptor signalling across smooth-muscle, vascular and immune physiology.
How do tissue type and receptor subtype affect Vasoactive Intestinal Peptide studies?
Smooth-muscle and immune-signalling studies examine different receptor-mediated endpoints. The tissue, receptor subtype and experimental preparation shape interpretation.
How does extensive VIP physiology differ from limited human intervention evidence?
VIP / Vasoactive Intestinal Peptide has extensive physiological research but only limited small human intervention studies for specific questions. This does not establish a generic therapeutic use.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.